China’s annual drug licensing share hit 30% of global deals

news image
Q1 2026 brought $60B in outbound deals from Chinese drug developers. Why China captures that spillover is structural. It is harder to unwind than the deal flow suggests…
阅读更多(Read More)

作者 liangfm-2